摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2’,5’-二甲基联苯-3-羧酸 | 1181626-10-7

中文名称
2’,5’-二甲基联苯-3-羧酸
中文别名
2`,5`-二甲基联苯-3-羧酸
英文名称
2',5'-Dimethyl-[1,1'-biphenyl]-3-carboxylic acid
英文别名
3-(2,5-dimethylphenyl)benzoic acid
2’,5’-二甲基联苯-3-羧酸化学式
CAS
1181626-10-7
化学式
C15H14O2
mdl
——
分子量
226.275
InChiKey
ABYDLDPPTUIJHA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2916399090

反应信息

  • 作为反应物:
    描述:
    2’,5’-二甲基联苯-3-羧酸草酰氯三乙胺 作用下, 以 二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 6.0h, 生成 CYM50367
    参考文献:
    名称:
    SAR analysis of innovative selective small molecule antagonists of sphingosine-1-phosphate 4 (S1P4) receptor
    摘要:
    Recent evidence suggests an innovative application of chemical modulators targeting the S1P(4) receptor as novel mechanism-based drugs for the treatment of influenza virus infection. Modulation of the S1P(4) receptor may also represent an alternative therapeutic approach for clinical conditions where reactive thrombocytosis is an undesired effect or increased megakaryopoiesis is required. With the exception of our recent research program disclosure, we are not aware of any selective S1P(4) antagonists reported in the literature to date. Herein, we describe complementary structure-activity relationships (SAR) of the high-throughput screening (HTS)-derived hit 5-(2,5-dichlorophenyl)-N-(2,6-dimethylphenyl)furan-2-carboxamide and its 2,5-dimethylphenyl analog. Systematic structural modifications of the furan ring showed that both steric and electronic factors in this region have a significant impact on the potency. The furan moiety was successfully replaced with a thiophene or phenyl ring maintaining potency in the low nanomolar range and high selectivity against the other S1P receptor subtypes. By expanding the molecular diversity within the hit-derived class, our SAR study provides innovative small molecule potent and selective S1P(4) antagonists suitable for in vivo pharmacological validation of the target receptor. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.06.132
  • 作为产物:
    描述:
    3-溴苯甲酸甲酯potassium phosphate 、 palladium diacetate 、 lithium hydroxide 、 三环己基膦 作用下, 以 四氢呋喃甲醇甲苯 为溶剂, 反应 15.0h, 生成 2’,5’-二甲基联苯-3-羧酸
    参考文献:
    名称:
    SAR analysis of innovative selective small molecule antagonists of sphingosine-1-phosphate 4 (S1P4) receptor
    摘要:
    Recent evidence suggests an innovative application of chemical modulators targeting the S1P(4) receptor as novel mechanism-based drugs for the treatment of influenza virus infection. Modulation of the S1P(4) receptor may also represent an alternative therapeutic approach for clinical conditions where reactive thrombocytosis is an undesired effect or increased megakaryopoiesis is required. With the exception of our recent research program disclosure, we are not aware of any selective S1P(4) antagonists reported in the literature to date. Herein, we describe complementary structure-activity relationships (SAR) of the high-throughput screening (HTS)-derived hit 5-(2,5-dichlorophenyl)-N-(2,6-dimethylphenyl)furan-2-carboxamide and its 2,5-dimethylphenyl analog. Systematic structural modifications of the furan ring showed that both steric and electronic factors in this region have a significant impact on the potency. The furan moiety was successfully replaced with a thiophene or phenyl ring maintaining potency in the low nanomolar range and high selectivity against the other S1P receptor subtypes. By expanding the molecular diversity within the hit-derived class, our SAR study provides innovative small molecule potent and selective S1P(4) antagonists suitable for in vivo pharmacological validation of the target receptor. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.06.132
点击查看最新优质反应信息

文献信息

  • [EN] 1,4-DISUBSTITUTED NAPHTALENES AS INHIBITORS OF P38 MAP KINASE<br/>[FR] NAPHTALENES DISUBSTITUES EN POSITION 1,4 UTILISES COMME INHIBITEURS DE MAP KINASE P38
    申请人:ARQULE INC
    公开号:WO2006010082A1
    公开(公告)日:2006-01-26
    In general, the present invention relates to compounds capable of inhibiting P38, methods for inhibiting P38 in vivo or in vitro, diagnostics for determining activity in the treatment of P38 and/or cytokine-associated conditions and methods for treating conditions associated with P38 activity or cytokine activity.
    一般而言,本发明涉及能够抑制P38的化合物,用于体内或体外抑制P38的方法,用于诊断治疗P38和/或细胞因子相关疾病活性的诊断方法,以及用于治疗与P38活性或细胞因子活性相关的疾病的方法。
  • 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase
    申请人:Ashwell A. Mark
    公开号:US20080032967A1
    公开(公告)日:2008-02-07
    In general, the present invention relates to compounds capable of inhibiting P38, methods for inhibiting P38 in vivo or in vitro, diagnostics for determining activity in the treatment of P38 and/or cytokine-associated conditions and methods for treating conditions associated with P38 activity or cytokine activity.
    总的来说,本发明涉及能够抑制P38的化合物,抑制P38在体内或体外的方法,用于确定在治疗P38和/或细胞因子相关疾病中的活性的诊断方法,以及用于治疗与P38活性或细胞因子活性相关的疾病的方法。
  • US7829560B2
    申请人:——
    公开号:US7829560B2
    公开(公告)日:2010-11-09
  • [EN] DISAZO DYES<br/>[FR] COLORANTS DISAZO
    申请人:ZENECA LIMITED
    公开号:WO1995000592A1
    公开(公告)日:1995-01-05
    (EN) Compounds of formula (1) and salts thereof, wherein: T1 and T2 each independently is H, acyl or optionally substituted alkyl or aryl; or T1 and T2 together represent an optionally substituted hydrocarbylene optionally interrupted by oxygen; D is optionally substituted phenylene or naphthylene; E is optionally substituted naphthylene or quinolinylene; Z is H or optionally substituted aryl; and n has a value of 0 or 1; provided that T1, T2 and Z are not all H when n has a value of 0 and their use in inks, especially ink jet printing inks, for paper.(FR) Composés de la formule (1) et leurs sels, dans laquelle T1 et T2 représentent indépendamment H, acyle ou alkyle ou aryle éventuellement substitué; ou T1 et T2 représentent ensemble un hydrocarbylène éventuellement substitué, éventuellement interrompu par oxygène; D représente phénylène ou naphtylène éventuellement substitué; E représente naphtylène ou quinolinylène éventuellement substitué; Z représente H ou aryle éventuellement substitué; et n vaut 0 ou 1; à condition que T1, T2 et Z ne représentent pas tous H lorsque n vaut 0 ou 1. L'invention se rapporte également à leur utilisation dans des encres, en particulier des encres pour impression à jet d'encre sur du papier.
  • [EN] DISAZO COMPOUND<br/>[FR] COMPOSE DISAZO
    申请人:ZENECA LIMITED
    公开号:WO1995017471A1
    公开(公告)日:1995-06-29
    (EN) A compound of Formula (1) and salts thereof wherein: L is optionally substituted piperazinyl; D is optionally substituted phenylene or naphthylene; E is optionally substituted phenylene, naphthylene or quinoline; R is H or C1-4-alkyl; Z is optionally substituted carboxyaryl; and n has a value of 0 or 1. A compound of formula (1) is useful as a colorant for black inks suitable for ink jet printing.(FR) Composé de la formule (1) ainsi que ses sels. Dans cette formule, L est pipérazinyle facultativement substitué; D est phénylène ou naphtylène facultativement substitué; E est phénylène, naphtylène ou quinoléine facultativement substitué; R représente H ou alcoyle C1-4; Z est carboxyaryle facultativement substitué; et n vaut 0 ou 1. Ce composé de la formule (1) est utile en tant que colorant pour des encres noires appropriées à l'impression par jet d'encre.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫